↓ Skip to main content

Dove Medical Press

Update on Safety Profiles of Vitamins B1, B6, and B12: A Narrative Review

Overview of attention for article published in Therapeutics and Clinical Risk Management, December 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#39 of 1,323)
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
5 news outlets
twitter
1 X user
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
80 Mendeley
Title
Update on Safety Profiles of Vitamins B1, B6, and B12: A Narrative Review
Published in
Therapeutics and Clinical Risk Management, December 2020
DOI 10.2147/tcrm.s274122
Pubmed ID
Authors

Carlos-Alberto Calderon-Ospina, Mauricio Orlando Nava-Mesa, Ana María Paez-Hurtado

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 80 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 10%
Other 8 10%
Student > Bachelor 8 10%
Professor > Associate Professor 5 6%
Student > Ph. D. Student 4 5%
Other 7 9%
Unknown 40 50%
Readers by discipline Count As %
Medicine and Dentistry 13 16%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Biochemistry, Genetics and Molecular Biology 4 5%
Agricultural and Biological Sciences 4 5%
Neuroscience 3 4%
Other 8 10%
Unknown 42 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 44. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2023.
All research outputs
#943,203
of 25,387,668 outputs
Outputs from Therapeutics and Clinical Risk Management
#39
of 1,323 outputs
Outputs of similar age
#25,613
of 518,694 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 19 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 518,694 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.